Bezerra S M, dos Santos C M, Moreira E D, Krieger E M, Michelini L C
Department of Physiology and Biophysics, ICB, University of São Paulo, São Paulo, SP, Brazil.
Hypertension. 2001 Sep;38(3 Pt 2):569-75. doi: 10.1161/hy09t1.095393.
In the coarctation hypertension model, we have shown that chronic treatment with losartan causes both normalization of impaired reflex control of heart rate and partial correction of the depressed aortic nerve activity/pressure relationship, even with the persistence of hypertension. In the present study, we analyzed the effects of angiotensin II blockade on the efferent pathways of coarcted and sham-operated groups treated chronically with vehicle or losartan (10 mg/kg per day PO). Hypertension was induced by subdiaphragmatic aortic coarctation, and the treatments lasted 9 days (4 control and 5 experimental days). On day 5, autoregressive power spectral analysis was performed on heart rate recordings made in conscious rats. Other groups were used for sympathetic splanchnic nerve activity recordings made simultaneously with pressure (anesthetized rats) at basal condition and during loading/unloading of baroreceptors. Losartan treatment induced a significant reduction in basal pressure but did not interfere with the development of hypertension (similar pressure increases of 24% and 28% over control values in losartan and vehicle groups, respectively). In vehicle-treated rats, establishment of hypertension was accompanied by a marked change in power spectral density from high- (1.19+/-0.06 Hz, 33+/-6%) to low-frequency components (0,42+/-0.03 Hz, 54+/-6%), with increased low-frequency-to-high-frequency ratio. When compared with sham-operated vehicle-treated rats, there was also increase in the gain of sympathetic activity/pressure relationship, with displacement of lower plateau toward high levels of sympathetic activity. No changes in the power spectral density and sympathetic activity/pressure relationship were observed when hypertension developed in the presence of chronic angiotensin type 1 (AT(1)) receptor blockade. The data suggest that angiotensin II, activated during the establishment of coarctation hypertension, acts via AT(1) receptors to alter sympathovagal balance, facilitating the sympathetic outflow to heart and peripheral circulation during baroreceptors unloading. Data also indicate that the observed effects are not conditioned by preexisting pressure levels.
在缩窄性高血压模型中,我们已经表明,即使高血压持续存在,长期使用氯沙坦治疗可使受损的心率反射控制恢复正常,并部分纠正降低的主动脉神经活动/压力关系。在本研究中,我们分析了血管紧张素II阻断对长期接受载体或氯沙坦(每天口服10mg/kg)治疗的缩窄组和假手术组传出通路的影响。通过膈下主动脉缩窄诱导高血压,治疗持续9天(4天对照和5天实验)。在第5天,对清醒大鼠的心率记录进行自回归功率谱分析。其他组用于在基础状态和压力感受器加载/卸载期间同时记录交感内脏神经活动和压力(麻醉大鼠)。氯沙坦治疗可使基础血压显著降低,但不影响高血压的发展(氯沙坦组和载体组分别比对照值压力升高24%和28%,相似)。在接受载体治疗的大鼠中,高血压的建立伴随着功率谱密度从高频成分(1.19±0.06Hz,33±6%)到低频成分(0.42±0.03Hz,54±6%)的显著变化,低频与高频比值增加。与假手术载体治疗大鼠相比,交感神经活动/压力关系的增益也增加,较低平台向高水平交感神经活动偏移。当在慢性1型血管紧张素(AT(1))受体阻断存在下高血压发展时,未观察到功率谱密度和交感神经活动/压力关系的变化。数据表明,在缩窄性高血压建立过程中激活的血管紧张素II通过AT(1)受体起作用,改变交感迷走平衡,在压力感受器卸载期间促进交感神经向心脏和外周循环的输出。数据还表明,观察到的效应不受先前存在的压力水平的影响。